LINDSEY SEAVER: Open Payments
NPI 1528461019 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 60 payments from 16 companies in 2025. Trend: 2023 $837 · 2024 $1,221 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $233 |
| Novo Nordisk Inc | 10 | $212 |
| Amgen Inc. | 12 | $151 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Medtronic, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
Products named: VRAYLAR, Wegovy, OTEZLA, AIRSUPRA, JARDIANCE, INCEPTIV, Ozempic, LINZESS.
Industry payments across NC — which companies pay providers there.
